Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity
作者:Manuel de Lera Ruiz、Junying Zheng、Michael Y. Berlin、Kevin D. McCormick、Robert G. Aslanian、Robert West、Joyce Hwa、Jean Lachowicz、Margaret van Heek
DOI:10.1016/j.bmcl.2013.08.013
日期:2013.11
A novel series of non-imidazole bicyclic and tricyclic histamine H3 receptor antagonists has been discovered. Compound 17 was identified as a centrally penetrant molecule with high receptor occupancy which demonstrates robust oral activity in rodent models of obesity. In addition compound 17 possesses clean CYP and hERG profiles and shows no behavioral changes in the Irwin test.
已经发现了一系列新的非咪唑双环和三环组胺H 3受体拮抗剂。化合物17被确定为具有高受体占有率的中央渗透分子,在肥胖的啮齿动物模型中显示出强大的口服活性。此外,化合物17具有干净的CYP和hERG谱,在Irwin测试中未显示任何行为变化。